148 related articles for article (PubMed ID: 32334486)
1. Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders.
Pokala A; Paramkusam G; Tejaswi MLA; Bangi BB; Nadendla LK; Devulapally RV
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1163-1166. PubMed ID: 32334486
[TBL] [Abstract][Full Text] [Related]
2. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
3. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
Sawhney H; Kumar CA
Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
[TBL] [Abstract][Full Text] [Related]
5. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization.
Gao S; Bennett EP; Reibel J; Chen X; Christensen ME; Krogdahl A; Dabelsteen E
APMIS; 2004 Jan; 112(1):11-20. PubMed ID: 14961969
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and Immunohistochemistry.
Arora KS; Nayyar A; Kaur P; Arora KS; Goel A; Singh S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1075-1080. PubMed ID: 29699065
[TBL] [Abstract][Full Text] [Related]
7. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
Singh A; Purohit BM
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1703-1712. PubMed ID: 34181324
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity.
Anil S; Beena VT; Nair RG; Vijayakumar T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):750-2. PubMed ID: 7621034
[TBL] [Abstract][Full Text] [Related]
9. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
10. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
11. Exploratory Study to Evaluate Changes in Serum Lipid Levels as Early Diagnostic and/or Prognostic Indicators for Oral Submucous Fibrosis and Cancer among Gutkha Consumers in India.
Agarwal A; Tijare M; Saxena A; Rubens M; Ahuja R
Asian Pac J Cancer Prev; 2015; 16(15):6439-44. PubMed ID: 26434856
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
Ganavi BS; Patil S; Rao RS
J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
[TBL] [Abstract][Full Text] [Related]
14. The use of CA-IX as a diagnostic method for oral leukoplakia.
Pérez-Sayáns M; Suárez-Peñaranda JM; Torres-López M; Supuran CT; Gándara-Vila P; Gayoso-Diz P; Barros-Angueira F; Gallas-Torreira M; García-García A
Biotech Histochem; 2015 Feb; 90(2):124-31. PubMed ID: 25297562
[TBL] [Abstract][Full Text] [Related]
15. A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa.
Sumedha S; Kotrashetti VS; Somannavar P; Nayak R; Babji D
Biotech Histochem; 2015 May; 90(4):264-9. PubMed ID: 25539051
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
17. Epithelial isoantigens A, B and H in oral carcinomas.
Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
[No Abstract] [Full Text] [Related]
18. [Value of squamous cell epithelial-associated (SCC-) antigens in early diagnosis of oral carcinoma].
Zöller J; Mende U; Fiehn W
ZWR; 1990 Dec; 99(12):981-2, 984-5. PubMed ID: 2100453
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
20. Loss of intercellular substance antigens in oral hyperkeratosis, epithelial dysplasia, and squamous cell carcinoma.
Bovopoulou O; Sklavounou A; Laskaris G
Oral Surg Oral Med Oral Pathol; 1985 Dec; 60(6):648-54. PubMed ID: 3865137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
